Founding Sponsor:

Sponsored by:



With Support From:

As the overall costs associated with clinical development, regulatory approval process, and commercialization have steadily increased in the past several years, many medical device companies have utilized strategic partnerships and alliances as a means of defraying the costs, and potentially accelerating the timelines, associated with product development and commercialization. Alliances have also been formed to increase the sales and marketing reach and to capitalize upon new markets. These partnerships and alliances include a broad range of spectrum, from an early stage preclinical startup partnering with a multinational conglomerate to co-develop a new product, to established public companies cross licensing technology and entering into sales and marketing pacts. A panel of experts will explore the key issues, pros and cons, trends and other considerations related to strategic partnerships and alliances, and share their experiences.

The following will be among the topics explored: What trends are we seeing? What successes & failures are we seeing? Are strategic partnerships really going to reduce costs & speed cycle times? What are the best reasons for considering partnerships? What are the worst reasons for considering partnerships? How do you assess the risks of a partnership, and how do you equitably share those risks? Best practices for Identifying and measuring key performance metrics? Best practices for managing unforeseen problems?

Panel Moderator:

Frank F. Rahmani
Partner, Cooley Godward Kronish LLP

 

Panel Speakers:

Andrew Cleeland
President & CEO, Ardian, Inc.

Timothy Mills, PhD
Managing Director, Sanderling Ventures

Shahab Salemy
Director of Business Development, Medtronic CardioVascular

Jason Yip
Principal, Montgomery & Co.


 

• When: July 14, 8:00am - 10:00am
   
• Where: Cooley Godward Kronish LLP, Palo Alto, CA Directions.
  
• Attire: Business Attire Suggested

Registrations - THIS EVENT IS SOLD OUT

Early Bird Registration through July 10, 2009:
$10.00 BayBio and MDMA Members, Bio2Device and Bio-X Affiliates
$20.00 Non-Members

On-Site Registration, July 14, 2009:
$20.00 BayBio and MDMA Members
$40.00 Non-Members

• Pre-registered attendees will receive an immediate receipt/confirmation after submission.
  Please print this receipt/confirmation and bring it with you to receive your conference credentials.
  Photo ID (driver's license or passport) will be required at check-in.
• All sales are final - BayBio offers no refunds.

Please mail your event-related questions to: events@baybio.org or you can contact us via phone: 650-871-7101.
Is your company a member? Click here to check.
See how your company can save money by becoming a BayBio member!